Suchergebnisse - "Kambhampati, Suman"

PubPharm (102)

1

In-class transition from bortezomib-based therapy to IRd is an effective approach in newly diagnosed multiple myeloma

enthalten in: Future oncology (London, England) | 2024

von Rifkin, R. | Costello, C. | Birhiray, R. | +11

2

Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML : Phase Ib Results

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Daver, N. | Vyas, P. | Kambhampati, S. | +18

3

In-class transition (iCT) of proteasome inhibitor-based therapy : a community approach to multiple myeloma management

enthalten in: Blood cancer journal | 2023

von Rifkin, R. | Girnius, S. | Noga, S. | +9

4

Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes : Final Results of a Phase Ib Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Sallman, D. | Al Malki, M. | Asch, A. | +22

5

Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome : Result of a Phase II Clinical Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Gonzalez-Lugo, J. | Kambhampati, S. | Yacoub, A. | +20

6

Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML

enthalten in: Blood advances | 2022

von Adès, L. | Girshova, L. | Doronin, V. | +16

7

Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Desai, P. | Brown, J. | Gill, S. | +29

8

A Primer on Chimera Associated Receptor T-Cells

enthalten in: Missouri medicine | 2021

von Muthineni, S. | Zink, K. | Kambhampati, S.

9

Infection risks in multiple myeloma : a systematic review and meta-analysis of randomized trials from 2015 to 2019

enthalten in: BMC cancer | 2021

von Balmaceda, N. | Aziz, M. | Chandrasekar, V. | +10

10

Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019

enthalten in: BMC cancer | 2021

von Balmaceda, N. | Aziz, M. | Chandrasekar, V. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]